Abstract:ObjectiveTo identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism.DesignCase-control study and basic science.Materials and Methods65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used.Results(1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05).ConclusionOur findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way. ObjectiveTo identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism. To identify alternatively spliced variants of androgen receptor (AR) in granulosa cells (GCs) of polycystic ovary syndrome (PCOS) women, and to investigate their roles in ovarian hyperandrogenism. DesignCase-control study and basic science. Case-control study and basic science. Materials and Methods65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used. 65 PCOS women and 150 women with tubal blockage undergoing IVF-ET in our center were recruited. GCs and follicular fluids were collected during oocyte retrieval. GCs of 60 patients with tubal blockage were primarily cultured. We performed RT-PCR, realtime PCR, DNA sequencing, ELISA, adenovirus construction and infections. One-way ANOVA and t test were used. Results(1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05). (1) We found two abnormal alternatively spliced variants of AR in GCs, which comprised an insertion of a 69-bp fragment of intron2 or exon skipping of exon3; (2) All women expressed the wild type of AR variant, and their expression levels were comparable,however,insertion and deletion type were exclusively expressed in 50% and 14.7% of PCOS women separately; (3) For women with abnormal AR variant, serum total testosterone and dehydroepiandrosterone levels and free androgen index levels in follicular fluids were significantly higher compared with those without (P<0.05); (4)Since aromatase converts androgens into estrogens, lower mRNA expression of aromatase (CYP19A1) and reduced estradiol (E2)/TT and estrone/androstenedione (E1/A) ratio in follicular fluid were found in PCOS women with abnormal types of AR variant (P<0.05); (5) When infected in primary cultured GCs, both abnormal spliced variants showed dramatically decreased CYP19A1 mRNA level and E2/TT and E1/A ratio of culture media compared to wild type following dihydrotestosterone treatment (P<0.05). ConclusionOur findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way. Our findings strongly indicate abnormal alternatively spliced variants of AR as being an intrinsic epigenetic cause of androgen metabolism dysfunction in GCs, resulting in ovarian hyperandrogenism of PCOS. And our work to clarify its underlying mechanism is already under way.

Bisphenol a (BPA) induces abnormal androgen accumulation via androgen-androgen receptor (AR) mdiated cyp19a1 transcription inhibition in granulosa cells (GCs)

Bisphenol A Exposure Induces Testicular Oxidative Damage Via FTO/m6A/Nrf2 Axis During Postnatal Development in Mice.

The interference effects of bisphenol A on the synthesis of steroid hormones in human ovarian granulosa cells

Connecting Bisphenol A Exposure to PCOS: Findings from a Case-Control Investigation

BPA interferes with granulosa cell development and oocyte meiosis in mouse preantral follicles

Molecular Mechanism of Bisphenol A on Androgen Receptor Antagonism.

Does bisphenol A (BPA) participates in the pathogenesis of Polycystic Ovary Syndrome (PCOS)?

Bisphenol-A exposure and gene expression in human luteinized membrana granulosa cells in vitro

Gestational Exposure to Bisphenol AF Causes Endocrine Disorder of Corpus Luteum by Altering Ovarian SIRT-1/Nrf2/NF-kB Expressions and Macrophage Proangiogenic Function in Mice.

The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis

Bisphenol a downregulates GLUT4 expression by activating aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome

Bisphenol A and polycystic ovary syndrome in human: A systematic review

Alternatively spliced variants of androgen receptor in granulosa cells: an epigenetic cause of ovarian hyperandrogenism of polycystic ovary syndrome

A Molecular Mechanism Underlying Ovarian Dysfunction of Polycystic Ovary Syndrome: Hyperandrogenism Induces Epigenetic Alterations in the Granulosa Cells

Exposure to Bisphenol A and Its Analogs and Polycystic Ovarian Syndrome in Women of Childbearing Age: A Multicenter Case-Control Study

Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome

Review on bisphenol A and the risk of polycystic ovarian syndrome: an insight from endocrine and gene expression

Urinary Bisphenol A Concentration is Correlated with Poorer Oocyte Retrieval and Embryo Implantation Outcomes in Patients with Tubal Factor Infertility Undergoing in Vitro Fertilisation.

The function of BAP18 on modulation of androgen receptor action in luteinized granulosa cells from normal weight women with and without PCOS

Bisphenol A promotes autophagy in ovarian granulosa cells by inducing AMPK/mTOR/ULK1 signalling pathway

Genetic and Epigenetic Profiles of Polycystic Ovarian Syndrome and In Vitro Bisphenol Exposure in a Human Granulosa Cell Model